Pembrolizumab and epigenetic modification with azacitidine reshapes the tumor microenvironment of platinum-resistant epithelial ovarian cancer: a phase 2 non-randomized clinical trial
帕博利珠单抗联合阿扎胞苷进行表观遗传修饰可重塑铂耐药性上皮性卵巢癌的肿瘤微环境:一项 II 期非随机临床试验
期刊:
影响因子:
doi:10.1038/s43856-026-01404-0
Landon, Blair V; Boland, Julia L; Wahner Hendrickson, Andrea E; Armstrong, Deborah K; Winterhoff, Boris; Wehr, Jaime; Annapragada, Akshaya V; Cherry, Christopher; Balan, Archana; Kaleka, Guneet; Velculescu, Victor E; Baylin, Stephen B; Zahnow, Cynthia A; Slamon, Dennis J; Konecny, Gottfried E; Anagnostou, Valsamo; Glaspy, John A